Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 32136-81-5 | MDL No. : | MFCD08461683 |
Formula : | C9H10O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HUXGFSJRCMJOAK-UHFFFAOYSA-N |
M.W : | 166.17 | Pubchem ID : | 3015614 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 44.55 |
TPSA : | 46.53 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.29 cm/s |
Log Po/w (iLOGP) : | 1.66 |
Log Po/w (XLOGP3) : | 1.44 |
Log Po/w (WLOGP) : | 1.22 |
Log Po/w (MLOGP) : | 0.56 |
Log Po/w (SILICOS-IT) : | 1.55 |
Consensus Log Po/w : | 1.29 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.95 |
Solubility : | 1.87 mg/ml ; 0.0112 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.02 |
Solubility : | 1.58 mg/ml ; 0.00949 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.29 |
Solubility : | 0.842 mg/ml ; 0.00507 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.19 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | With sodium hydroxide In methanol | EXAMPLE 3 Preparation of alpha-methoxy-4-hydroxyacetophenone 2 g of alpha-bromo-4-hydroxyacetophenone are dissolved in 11 g of methanol. 30 g of a saturated solution of sodium hydroxide in methanol (1 g NaOH/ 4.2 ml methanol) is added dropwise to the alpha-bromo-4-hydroxyacetophenone solution. After the addition is complete, the solution is added to 30 g of ice and acidified to pH 6. Alpha-methoxy-4-hydroxyacetophenone precipitates out and is filtered and dried to a greenish yellow product in about 85percent yield; the product is determined by 1-H-NMR to be substantially pure. |
[ 19513-80-5 ]
2-(2-Methoxyphenoxy)-1-(4-methoxyphenyl)ethanone
Similarity: 0.88
[ 38250-16-7 ]
Methyl 2-(4-hydroxyphenyl)-2-oxoacetate
Similarity: 0.85
[ 2657-25-2 ]
1-(4-Hydroxyphenyl)-3-phenylprop-2-en-1-one
Similarity: 0.82
[ 43113-93-5 ]
1-(3-Hydroxy-5-methylphenyl)ethanone
Similarity: 0.82
[ 19513-80-5 ]
2-(2-Methoxyphenoxy)-1-(4-methoxyphenyl)ethanone
Similarity: 0.88
[ 6161-64-4 ]
1-(2-Methoxy-6-methylphenyl)ethanone
Similarity: 0.82
[ 19513-80-5 ]
2-(2-Methoxyphenoxy)-1-(4-methoxyphenyl)ethanone
Similarity: 0.88
[ 38250-16-7 ]
Methyl 2-(4-hydroxyphenyl)-2-oxoacetate
Similarity: 0.85